PDS Planning, Inc

Position in RDY — Dr Reddys Laboratories Ltd

CIK 838618 DUBLIN, OH

Position in RDY

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$899,872

+$138,164 QoQ

Shares Held

62,103

+12.9% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#15

of 90 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

PDS Planning, Inc holds $1,750,619 across 5 Drug Manufacturers - Specialty & Generic names. RDY ranks #1 (51.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RDY	Dr Reddys Laboratories Ltd This page	62,103	$899,872
2	TEVA	Teva Pharmaceutical Industries Ltd	8,116	$274,970
3	TAK	Takeda Pharmaceutical Co Ltd	17,116	$274,369
4	HLN	Haleon plc	26,196	$244,408
5	AKBA	Akebia Therapeutics, Inc.	50,000	$57,000

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$899,872	62,103	+12.9%	Shares	Sole	2026-08-05
2026-03-31	$761,708	54,997	+21.2%	Shares	Sole	2026-04-22
2025-12-31	$637,177	45,383	+1.3%	Shares	Sole	2026-01-26
2025-09-30	$626,471	44,812	-0.6%	Shares	Sole	2025-10-21
2025-06-30	$677,792	45,096	+14.4%	Shares	Sole	2025-07-24
2025-03-31	$519,883	39,415	+22.2%	Shares	Sole	2025-04-24
2024-12-31	$509,290	32,254	+389.3%	Shares	Sole	2025-02-10
2024-09-30	$523,734	6,592	-0.7%	Shares	Sole	2024-10-30
2024-06-30	$505,977	6,641	+16.8%	Shares	Sole	2024-08-08
2024-03-31	$416,921	5,684	+8.5%	Shares	Sole	2024-05-01
2023-12-31	$364,529	5,239	+6.3%	Shares	Sole	2024-02-01
2023-09-30	$329,669	4,930	+6.8%	Shares	Sole	2023-10-23
2023-06-30	$291,441	4,618	+2.4%	Shares	Sole	2023-07-21
2023-03-31	$256,697	4,509	—	Shares	Sole	2023-05-02
No filing history on record for this holder in this stock.